This brand name is authorized in Spain, France, Ireland, United Kingdom
The drug RENOCIS contains one active pharmaceutical ingredient (API):
|
1
Technetium ⁹⁹ᵐTc succimer
UNII DX1U2629QE - SUCCIMER
|
|
|
Below package inserts are available for further reading:
| Title | Information Source | Document Type | |
|---|---|---|---|
| RENOCIS Kit for radiopharmaceutical preparation | Health Products Regulatory Authority (IE) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| V09CA02 | Technetium (99mTc) succimer | V Various → V09 Diagnostic radiopharmaceuticals → V09C Renal system → V09CA Technetium (99mTc) compounds |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 69828 |
| Country: FR | Base de données publique des médicaments | Identifier(s): 62717286 |
| Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 393362 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
